Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | NSD2 | O96028 | 1/20 | 0.59 |
| ▸ | HTR1B | P28222 | 2/20 | 0.51 |
| ▸ | HTR1D | P28221 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.50 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.50 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.47 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.47 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25822284 | 0.89 | KDM4E (0.51) | KDM4ESMN1; SMN2ALDH1A1NSD2HPGD | |
| SCHEMBL27439170 | 0.87 | KMT2A (0.55) | KDM4ESMN1; SMN2HPGDMEN1KMT2A | |
| SCHEMBL8901248 | 0.87 | KDM4E (0.62) | KDM4ESMN1; SMN2ALDH1A1NSD2HTR1B | |
| SCHEMBL25822288 | 0.87 | KDM4E (0.62) | KDM4ESMN1; SMN2ALDH1A1NSD2HTR1B | |
| SCHEMBL2206370 | 0.85 | SMN1; SMN2 (0.52) | KDM4ESMN1; SMN2ALDH1A1NSD2HPGD | |
| SCHEMBL29818936 | 0.85 | SMN1; SMN2 (0.52) | KDM4ESMN1; SMN2ALDH1A1NSD2HPGD | |
| SCHEMBL19291537 | 0.85 | HPGD (0.54) | KDM4ESMN1; SMN2ALDH1A1NSD2HPGD | |
| SCHEMBL25820408 | 0.83 | KDM4E (0.58) | KDM4ESMN1; SMN2ALDH1A1NSD2HTR1B | |
| SCHEMBL353032 | 0.81 | HPGD (0.63) | SMN1; SMN2ALDH1A1HPGDMEN1KMT2A | |
| SCHEMBL13881713 | 0.80 | KDM4E (0.60) | KDM4ESMN1; SMN2ALDH1A1NSD2HTR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230218549-A1 | ALKOXY COMPOUNDS FOR DISEASE TREATMENT | ACUCELA INC. | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230218549-A1 | ALKOXY COMPOUNDS FOR DISEASE TREATMENT | ALDH1A2, CLN6, AGER | KDM4E 2227/4885SMN1; SMN2 39/4885ALDH1A1 133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.